Clinical trial No longer in our active list Interventional Ages 18 and up

Training to help individuals with neglect after stroke

Official title: Examining Metacognitive Strategy Training for Individuals With Unilateral Spatial Neglect

Run by University of Pittsburgh · NCT06400147 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new training program to help people who have had a stroke and struggle with paying attention to one side of their body or surroundings, to see if it can improve their awareness and daily functioning.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment38 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
Trial IDNCT06400147 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have had a stroke and exhibit signs of unilateral neglect.

Probably not a fit

Patients with severe global aphasia, dementia, or active major psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on individuals who have experienced a stroke and suffer from unilateral spatial neglect, a condition that impairs their ability to pay attention to one side of their body or environment. It aims to evaluate the effectiveness of metacognitive strategy training, which teaches participants to set personal goals, self-assess their daily activities, and develop strategies to improve their performance. The study will measure the impact of this training on self-awareness, disability, and the severity of neglect symptoms. By tailoring the intervention specifically for individuals with neglect, the study seeks to provide new insights into effective treatment options for this population.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce disability and improve daily functioning for stroke survivors with neglect.

How similar studies have gone: While strategy training shows promise, this specific approach tailored for individuals with neglect has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* primary diagnosis of stroke
* admission to inpatient rehabilitation facility
* ≥18 years old
* presence of neglect as determined by score of \<18 on the Virtual Reality Lateralized Attention Test (VRLAT) or score below established cutoff for neglect on one of the six subtests of the Behavioral Inattention Test (BIT)

Exclusion Criteria:

* Boston Diagnostic Aphasia Examination (BDAE) Severity Scale score of 0 (severe global aphasia)
* diagnosis of dementia indicated in medical record
* diagnosis of active major depressive disorder/bipolar/psychotic disorder indicated in medical record
* anticipated length of stay \<10 days

Where it's running

  • University of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Emily Grattan, PhD — University of Pittsburgh
  • Study coordinator: Emily Grattan, PhD
  • Email: esg39@pitt.edu
  • Phone: 412-648-0619

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.